[Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
D000328:Adult; D002908:Chronic Disease; D004983:Ethanolamines / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000209:etiology; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D007741:Labetalol / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011704:Pyelonephritis / Q000150:complications
D004983:Ethanolamines; D007741:Labetalol
Effetto del trattamento con labetalolo sulla funzione renale nella ipertensione arteriosa secondaria a nefropatia parenchimale e nella ipertensione arteriosa essenziale.